Prostate cancer and serum PSA among users of serum lipid-lowering drugs in the Finnish prostate cancer screening trial

被引：2
|
作者：
Murtola, T.
Tammela, T.
Maeaettaenen, L.
Auvinen, A.
机构：
[1] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
[2] Tampere Univ Hosp, Dept Urol, Tampere, Finland
[3] Finnish Canc Registry, Prostate Canc Screening Study, FIN-00170 Helsinki, Finland
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2007年 / 6卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(07)60798-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [1] Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial
    Murtola, Teemu J.
    Tammela, Teuvo L. J.
    Maattanen, Liisa
    Huhtala, Heini
    Platz, Elizabeth A.
    Ala-Opas, Martti
    Stenman, Ulf-Hakan
    Auvinen, Anssi
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (07) : 1650 - 1659
  • [2] Prostate cancer and serum PSA-values among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
    Murtola, Teemu
    Tammela, Teuvo
    Maattanen, Liisa
    Stenman, Ulf-Hakan
    Auvinen, Anssi
    [J]. CANCER RESEARCH, 2009, 69
  • [3] PROSTATE CANCER AND SERUM PSA-VALUES AMONG FINASTERIDE AND ALPHA-BLOCKER USERS IN THE FINNISH PROSTATE CANCER SCREENING TRIAL
    Murtola, T.
    Tammela, T. L. J.
    Maattanen, L.
    Stenman, U. H.
    Auvinen, A.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 193 - 193
  • [4] Prostate Cancer and PSA Among Statin Users in the Finnish Prostate Cancer Screening Trial Editorial Comment
    Walsh, Patrick C.
    [J]. JOURNAL OF UROLOGY, 2010, 184 (01): : 175 - 176
  • [5] Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial
    K. J. Kaapu
    T. J. Murtola
    L. Määttänen
    K. Talala
    K. Taari
    T. L. J. Tammela
    A. Auvinen
    [J]. Cancer Causes & Control, 2016, 27 : 157 - 164
  • [6] Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial
    Kaapu, K. J.
    Murtola, T. J.
    Maattanen, L.
    Talala, K.
    Taari, K.
    Tammela, T. L. J.
    Auvinen, A.
    [J]. CANCER CAUSES & CONTROL, 2016, 27 (02) : 157 - 164
  • [7] Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial
    Yli-Hemminki, Tytti H.
    Laurila, Marita
    Auvinen, Anssi
    Maattanen, Liisa
    Huhtala, Heini
    Tammela, Teuvo L. J.
    Kujala, Paula M.
    [J]. BJU INTERNATIONAL, 2013, 112 (06) : 735 - 741
  • [8] Serum lipid-lowering drugs and prostate cancer risk - A population based case-control study
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 316 - 316
  • [9] Re: Histological Inflammation and Risk of Subsequent Prostate Cancer among Men with Initially Elevated Serum Prostate-Specific Antigen (PSA) Concentration in the Finnish Prostate Cancer Screening Trial
    Schaeffer, Edward M.
    [J]. JOURNAL OF UROLOGY, 2014, 191 (06): : 1808 - 1808
  • [10] Specificity of prostate cancer screening with PSA:: Finnish ERSPC trial
    Tammela, TL
    Auvinen, A
    Määttänen, L
    Stenman, UH
    Ala-Opas, M
    Ruutu, M
    Juusela, H
    Hakama, M
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 431 - 431
12345